Translational Development Acquisition Corp. (TDACW)
| Market Cap | 262.67M |
| Revenue (ttm) | n/a |
| Net Income | 6.21M |
| EPS | 0.28 |
| Shares Out | 21.91M |
| PE Ratio | 42.28 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 19,360 |
| Open | 1.390 |
| Previous Close | 1.390 |
| Day's Range | 1.260 - 1.390 |
| 52-Week Range | 0.060 - 2.450 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About TDACW
Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
News
ProLogium to become public through Translational Development Acquisition pact
ProLogium and Translational Development Acquisition (TDAC) announced they have entered into a definitive agreement for a business combination that would result in ProLogium becoming a publicly listed ...
Battery maker ProLogium to list on Nasdaq in $3.8 billion SPAC deal
Taiwanese battery maker ProLogium Technology will go public in New York through a merger with blank-check vehicle Translational Development Acquisition Corp in a $3.8 billion deal, the companies ann...
ProLogium, a Next Generation Solid-State Battery Developer with 10+ Years of Proven Commercialization, to List on the Nasdaq through a Merger with Translational Development Acquisition Corp.
ProLogium reached commercial-scale manufacturing for solid-state batteries in 2013, later delivered the world's first solid-state battery demo car with ENOVATE Motor in 2019. ProLogium has shipped a ...